Milestone Pharmaceuticals Inc. (MIST)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch MIST
See up to 3 months of MIST. The 7-day demo opens the 1M and 3M ranges and puts MIST on your watchlist.
Start 7-day demoLatest MIST insider trades
- Joseph Oliveto - OfficerOpen-market sale$82K
David Bharucha - OfficerOpen-market sale$135K
About Milestone Pharmaceuticals Inc. (MIST)
Milestone Pharmaceuticals Inc. is an SEC registrant, filing under CIK 0001408443, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
MIST Form 4 activity by transaction type, last 90 days
No Form 4 activity for MIST in the last 90 days.
MIST insider transactions (Form 4)
7332 Form 4 filings on record, the earliest from Jun 10, 2025, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Lisa M. Giles | Grant or award | Stock Option (right to buy) | 77,000 | $0.00 | - | |
| Seth H. Z. Fischer | Grant or award | Stock Option (right to buy) | 77,000 | $0.00 | - | |
| Stuart Duty | Grant or award | Stock Option (right to buy) | 77,000 | $0.00 | - | |
| Robert James Wills | Grant or award | Stock Option (right to buy) | 77,000 | $0.00 | - | |
 Michael John Tomsicek | Grant or award | Stock Option (right to buy) | 77,000 | $0.00 | - | |
 Andrew Saik | Grant or award | Stock Option (right to buy) | 77,000 | $0.00 | - | |
 Joseph C. Papa | Grant or award | Stock Option (right to buy) | 77,000 | $0.00 | - | |
| Joseph Oliveto - Officer | Open-market sale | Common Shares | 36,500 | $2.26 footnote F2 | $82K | |
| ||||||
| Joseph Oliveto - Officer | Grant or award | Employee Stock Option (right to buy) | 679,000 | $0.00 | - | |
| David Bharucha - Officer | Grant or award | Employee Stock Option (right to buy) | 204,000 | $0.00 | - | |
| Jeffrey Edward Nelson - Officer | Grant or award | Employee Stock Option (right to buy) | 204,000 | $0.00 | - | |
| Lorenz Muller - Officer | Grant or award | Employee Stock Option (right to buy) | 204,000 | $0.00 | - | |
 Amit Hasija - Officer | Grant or award | Employee Stock Option (right to buy) | 204,000 | $0.00 | - | |
| Lorenz Muller - Officer | Grant or award | Employee Stock Option (right to buy) | 204,000 | $0.00 | - | |
| Lorenz Muller - Officer | Grant or award | Restricted Stock Unit | 136,000 | $0.00 | - | |
| Amit Hasija - Officer | Grant or award | Employee Stock Option (right to buy) | 204,000 | $0.00 | - | |
| Amit Hasija - Officer | Grant or award | Restricted Stock Unit | 136,000 | $0.00 | - | |
| Jeffrey Edward Nelson - Officer | Grant or award | Employee Stock Option (right to buy) | 204,000 | $0.00 | - | |
| Jeffrey Edward Nelson - Officer | Grant or award | Restricted Stock Unit | 136,000 | $0.00 | - | |
| David Bharucha - Officer | Grant or award | Employee Stock Option (right to buy) | 204,000 | $0.00 | - | |
| David Bharucha - Officer | Grant or award | Restricted Stock Unit | 136,000 | $0.00 | - | |
| Joseph Oliveto - Officer | Grant or award | Employee Stock Option (right to buy) | 679,000 | $0.00 | - | |
| Joseph Oliveto - Officer | Grant or award | Restricted Stock Unit | 453,000 | $0.00 | - | |
| David Bharucha - Officer | Grant or award | Common Shares | 100,000 footnote F1 | - footnote F2 | - | |
| David Bharucha - Officer | Open-market sale | Common Shares | 58,007 | $2.32 footnote F4 | $135K | |
| David Bharucha - Officer | Option exercise | Common Shares | 20,100 | - footnote F5 | - | |
| David Bharucha - Officer | Open-market sale | Common Shares | 12,245 | $1.93 footnote F4 | $24K | |
| David Bharucha - Officer | Grant or award | Employee Stock Option (right to buy) | 100,000 | $0.00 | - | |
| David Bharucha - Officer | Option exercise | Restricted Stock Units | 20,100 | $0.00 | - | |
| ||||||
| Jeffrey Edward Nelson - Officer | Grant or award | Common Shares | 100,000 footnote F1 | - footnote F2 | - | |
| Jeffrey Edward Nelson - Officer | Open-market sale | Common Shares | 58,007 | $2.32 footnote F4 | $135K | |
| Jeffrey Edward Nelson - Officer | Option exercise | Common Shares | 20,100 | - footnote F5 | - | |
| Jeffrey Edward Nelson - Officer | Open-market sale | Common Shares | 12,245 | $1.93 footnote F4 | $24K | |
| Jeffrey Edward Nelson - Officer | Grant or award | Employee Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Jeffrey Edward Nelson - Officer | Option exercise | Restricted Stock Units | 20,100 | $0.00 | - | |
| ||||||
| Lorenz Muller - Officer | Grant or award | Common Shares | 100,000 footnote F1 | - footnote F2 | - | |
| Lorenz Muller - Officer | Open-market sale | Common Shares | 53,566 | $2.32 footnote F4 | $124K | |
| Lorenz Muller - Officer | Option exercise | Common Shares | 20,100 | - footnote F5 | - | |
| Lorenz Muller - Officer | Open-market sale | Common Shares | 11,180 | $1.93 footnote F4 | $22K | |
| Lorenz Muller - Officer | Grant or award | Employee Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Lorenz Muller - Officer | Option exercise | Restricted Stock Units | 20,100 | $0.00 | - | |
| ||||||
| Amit Hasija - Officer | Grant or award | Common Shares | 100,000 footnote F1 | - footnote F2 | - | |
| Amit Hasija - Officer | Open-market sale | Common Shares | 58,007 | $2.32 footnote F4 | $135K | |
| Amit Hasija - Officer | Option exercise | Common Shares | 20,100 | - footnote F5 | - | |
| Amit Hasija - Officer | Open-market sale | Common Shares | 12,245 | $1.93 footnote F4 | $24K | |
| Amit Hasija - Officer | Grant or award | Employee Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Amit Hasija - Officer | Option exercise | Restricted Stock Units | 20,100 | $0.00 | - | |
| ||||||
| Joseph Oliveto - Officer | Grant or award | Common Shares | 280,000 footnote F1 | - footnote F2 | - | |
| Joseph Oliveto - Officer | Open-market sale | Common Shares | 133,054 | $2.32 footnote F4 | $309K | |
| Joseph Oliveto - Officer | Option exercise | Common Shares | 66,600 | - footnote F5 | - | |
| Joseph Oliveto - Officer | Open-market sale | Common Shares | 34,523 | $1.93 footnote F4 | $67K | |
| Joseph Oliveto - Officer | Grant or award | Employee Stock Option (right to buy) | 280,000 | $0.00 | - | |
| Joseph Oliveto - Officer | Option exercise | Restricted Stock Units | 66,600 | $0.00 | - | |
| ||||||
| Joseph Oliveto - Officer | Open-market sale | Common Shares | 500 | $2.25 | $1K | |
| Joseph Oliveto - Officer | Open-market sale | Common Shares | 43,000 | $2.25 footnote F2 | $97K | |
| ||||||
| Amit Hasija - Officer | Grant or award | Common Shares | 50,000 | - | - | |
| Amit Hasija - Officer | Grant or award | Series A Common Warrants (right to buy) | 50,000 | - | - | |
| Amit Hasija - Officer | Grant or award | Series B Common Warrants (right to buy) | 50,000 | - | - | |
| Debra K. Liebert | Grant or award | Common Shares | 16,666 | - | - | |
| Debra K. Liebert | Grant or award | Series A Common Warrants (right to buy) | 16,793 | - | - | |
| Debra K. Liebert | Grant or award | Series B Common Warrants (right to buy) | 16,793 | - | - | |
| Robert James Wills | Grant or award | Common Shares | 50,000 | - | - | |
| Robert James Wills | Grant or award | Series A Common Warrants (right to buy) | 50,000 | - | - | |
| Robert James Wills | Grant or award | Series B Common Warrants (right to buy) | 50,000 | - | - | |
| David Bharucha - Officer | Grant or award | Common Shares | 53,333 | - | - | |
| David Bharucha - Officer | Grant or award | Series A Common Warrants (right to buy) | 53,333 | - | - | |
| David Bharucha - Officer | Grant or award | Series B Common Warrants (right to buy) | 53,333 | - | - | |
| Joseph Oliveto - Officer | Grant or award | Common Shares | 66,666 | - | - | |
| Joseph Oliveto - Officer | Grant or award | Series A Common Warrants (right to buy) | 66,666 | - | - | |
| Joseph Oliveto - Officer | Grant or award | Series B Common Warrants (right to buy) | 66,666 | - | - | |
| Lorenz Muller - Officer | Grant or award | Common Shares | 66,666 | - | - | |
| Lorenz Muller - Officer | Grant or award | Series A Common Warrants (right to buy) | 66,666 | - | - | |
| Lorenz Muller - Officer | Grant or award | Series B Common Warrants (right to buy) | 66,666 | - | - | |
Item 8.01, 9.01
Item 2.02, 9.01
Item 5.02, 5.07, 9.01
Item 2.02, 9.01
MIST insider trading FAQ
What is the latest insider trade for MIST?
Milestone Pharmaceuticals Inc. (MIST) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-12. The full record for MIST runs to 32 Form 4 filings, the earliest from 2025-06-10. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying MIST stock?
No insider purchases of MIST were filed in the last 90 days.
How many insiders are selling MIST stock?
No insider sales of MIST were filed in the last 90 days. 13 sales are on record for this company.
Where can I see MIST SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects MIST Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Lisa M. Giles view on EDGAR
- - Seth H. Z. Fischer view on EDGAR
- - Stuart Duty view on EDGAR
- - Robert James Wills view on EDGAR
- - Michael John Tomsicek view on EDGAR
- - Andrew Saik view on EDGAR
- - Joseph C. Papa view on EDGAR
- - Joseph Oliveto view on EDGAR
- - Joseph Oliveto view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where MIST's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow MIST with a 7-day demo
- MIST on your watchlist
- Every MIST Form 4 filing on record
- Up to 3 months of MIST price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
